1. Early-phase myocardial uptake intensity of 99m Tc-HMDP vs 99m Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.
- Author
-
Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Plante-Bordeneuve V, Dubois-Randé JL, Bodez D, Rosso J, Damy T, and Itti E
- Subjects
- Aged, Aged, 80 and over, Biopsy, Europe, Female, Humans, Male, Myocardium metabolism, Radionuclide Imaging, Regression Analysis, Technetium Tc 99m Medronate pharmacokinetics, Amyloid Neuropathies, Familial diagnostic imaging, Diphosphonates pharmacokinetics, Heart diagnostic imaging, Organotechnetium Compounds pharmacokinetics, Technetium Tc 99m Medronate analogs & derivatives
- Abstract
Background: This study sought to compare the intensity of early-phase myocardial uptake of two phosphonate-based radiotracers,
99m Tc-hydroxymethylene diphosphonate (HMDP) and99m Tc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD), in patients with hereditary transthyretin-related cardiac amyloidosis (TTR-CA)., Methods: Six patients with biopsy-proven diagnosis of TTR-CA and characteristic amyloid fibril composition underwent early-phase99m Tc-HMDP myocardial scintigraphy as part of their routine workup; they were later assessed by99m Tc-DPD scintigraphy after having signed informed written consent. Heart-to-mediastinum-ratio was measured at both time points as well as regional distribution on 17-segment analysis., Results: All patients had an H/M ratio >1.28 on both imaging.99m Tc-DPD uptake was slightly higher than99m Tc-HMDP uptake in 3 patients, but no statistical difference was found (P = 0.13). Regional distribution of the two radiotracers was well correlated on bull's eyes analysis, with only slight underestimation of99m Tc-DPD uptake in the anterior/apical segments, compared with99m Tc-HMDP., Conclusion:99m Tc-HMDP and99m Tc-DPD show comparable myocardial uptake intensity on early-phase scintigraphy and can be used alternatively for the diagnosis of TTR-CA.- Published
- 2018
- Full Text
- View/download PDF